Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 52 min ago
Peer-reviewedCC BY-NC-ND 4.0International Journal of Molecular Medicine

Centrosomal protein 55: Research progress on biological characteristics, disease associations and clinical translational potential (Review)

  1. 1Clinical Laboratory, Tiandong County Traditional Chinese Medicine Hospital, Baise, Guangxi 531500, P.R. China
  2. 2Nephrology Department, Tiandong County Traditional Chinese Medicine Hospital, Baise, Guangxi 531500, P.R. China
  3. 3Department of Hematology, Tianjin Medical University General Hospital, Tianjin 300052, P.R. China

Abstract

Centrosomal protein 55 (CEP55), a core member of the CEP centrosomal protein family, is a molecule that regulates cytokinesis during the end of cell division and is also extensively involved in multiple physiological processes, including genomic stability maintenance, immune regulation and embryonic development. It has been shown that CEP55 participates in pathological processes such as tumor cell proliferation, invasion, metastasis and immune escape by modulating multiple signaling pathways including PI3K/AKT, NF-κB and JAK/STAT. Furthermore, it exhibits a close correlation with poor prognosis among patients with cancer. In addition, dysregulated CEP55 expression is also implicated in the pathological processes of neurological disorders, reproductive-genetic diseases and chronic metabolic diseases. These findings highlight the potential clinical translational value of CEP55 for disease diagnosis, prognostic evaluation and targeted therapy. Based on recent domestic and international research, the present study systematically reviews the molecular biological properties, expression features and action mechanisms of CEP55 across multi-system diseases, and summarizes its clinical application potential, to provide a theoretical reference for promoting relevant basic research and implementing precise clinical diagnosis and treatment.

Related

  1. Micronized Bone Marrow and Niche Preservation: Biological Rationale, Preclinical Evidence, Translational Potential and Limitations
    Edward Jeffrey Donner, Johnny Huard
    CellsPeer-reviewedCC BY 4.0Cell biologyCrossref
  2. Biological characteristics and propagation of human rhinovirus-C in differentiated sinus epithelial cells
    S. Ashraf, R. Brockman-Schneider, Y. A. Bochkov +2
    VirologyPeer-reviewedLicence not statedFull text82 citedMicrobiologyHAL
  3. Biological sex and disease architecture in systemic sclerosis: a multilayer translational framework for precision medicine
    Yi’an Tian, Zhaofang Tian
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textImmunologyCrossrefEurope PMC
  4. Associations between social network characteristics and daily social experiences in later life: evidence from ecological momentary assessment
    Brea L Perry, Tianyao Qu, Siyun Peng +1
    The Journals of Gerontology Series B: Psychological Sciences and Social SciencesPeer-reviewedPublisher termsFull text1 citedNeurosciencePMC
  5. Astragalus cicer L. and Astragalus glycyphyllos L. Flowers as Potential Functional Foods: Nutritional Composition, Chemical Characterization, and Biological Activity
    Saba Shahrivari-Baviloliaei, Liege Aguiar Pascoalino, Filipa S. Reis +6
    Plants (Basel, Switzerland)Peer-reviewedCC BYFull textPlant biologyEurope PMC
BibTeX
@article{nong2026centrosomal,
  title = {{Centrosomal protein 55: Research progress on biological characteristics, disease associations and clinical translational potential (Review)}},
  author = {Sanmei Nong and Qiudong Huang and Kuibo Huang and Xiao Luo and Yin Huang and Wenlian Zheng and Weiyi Huang and Zhaoyun Liu},
  journal = {International Journal of Molecular Medicine},
  year = {2026},
  month = oct,
  doi = {10.3892/ijmm.2026.6017},
  url = {https://doi.org/10.3892/ijmm.2026.6017},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Centrosomal protein 55: Research progress on biological characteristics, disease associations and clinical translational potential (Review)
AU  - Sanmei Nong
AU  - Qiudong Huang
AU  - Kuibo Huang
AU  - Xiao Luo
AU  - Yin Huang
AU  - Wenlian Zheng
AU  - Weiyi Huang
AU  - Zhaoyun Liu
PY  - 2026
DA  - 2026/10/16
JO  - International Journal of Molecular Medicine
DO  - 10.3892/ijmm.2026.6017
UR  - https://doi.org/10.3892/ijmm.2026.6017
AB  - Centrosomal protein 55 (CEP55), a core member of the CEP centrosomal protein family, is a molecule that regulates cytokinesis during the end of cell division and is also extensively involved in multiple physiological processes, including genomic stability maintenance, immune regulation and embryonic development. It has been shown that CEP55 participates in pathological processes such as tumor cell proliferation, invasion, metastasis and immune escape by modulating multiple signaling pathways including PI3K/AKT, NF-κB and JAK/STAT. Furthermore, it exhibits a close correlation with poor prognosis among patients with cancer. In addition, dysregulated CEP55 expression is also implicated in the pathological processes of neurological disorders, reproductive-genetic diseases and chronic metabolic diseases. These findings highlight the potential clinical translational value of CEP55 for disease diagnosis, prognostic evaluation and targeted therapy. Based on recent domestic and international research, the present study systematically reviews the molecular biological properties, expression features and action mechanisms of CEP55 across multi-system diseases, and summarizes its clinical application potential, to provide a theoretical reference for promoting relevant basic research and implementing precise clinical diagnosis and treatment.
SN  - 1107-3756
SN  - 1791-244X
ER  -